Khiron Financial Statements From 2010 to 2026
Khiron Life's financial statements offer valuable quarterly and annual insights to potential investors, highlighting the company's current and historical financial position, overall management performance, and changes in financial standing over time. Key fundamentals influencing Khiron Life's valuation are provided below:Khiron Life Sciences does not presently have any fundamental ratios for analysis.
This module can also supplement various Khiron Life Technical models . Check out the analysis of Khiron Life Correlation against competitors.
Check Khiron Life financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Khiron Life's main balance sheet or income statement drivers, such as , as well as many indicators such as . Khiron financial statements analysis is a perfect complement when working with Khiron Life Valuation or Volatility modules.
Khiron |
Khiron Life Sciences Company Return On Asset Analysis
Khiron Life's Return on Asset or ROA shows how effective is the management of the company in generating income from utilizing all of the assets at their disposal. It is a useful ratio to evaluate the performance of different departments of a company as well as to understand management performance over time.
Current Khiron Life Return On Asset | -0.21 |
Most of Khiron Life's fundamental indicators, such as Return On Asset, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Khiron Life Sciences is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
Return on Asset measures overall efficiency of a company in generating profits from its total assets. It is expressed as the percentage of profits earned per dollar of Asset. A low ROA typically means that a company is asset-intensive and therefore will needs more money to continue generating revenue in the future.
| Competition |
Based on the latest financial disclosure, Khiron Life Sciences has a Return On Asset of -0.2079. This is 97.62% lower than that of the Healthcare sector and significantly lower than that of the Drug Manufacturers—Specialty & Generic industry. The return on asset for all United States stocks is 48.5% higher than that of the company.
Khiron Life Sciences Fundamental Drivers Relationships
Comparative valuation techniques use various fundamental indicators to help in determining Khiron Life's current stock value. Our valuation model uses many indicators to compare Khiron Life value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across Khiron Life competition to find correlations between indicators driving Khiron Life's intrinsic value. More Info.Khiron Life Sciences is rated fourth overall in return on equity category among its peers. It is rated fifth overall in return on asset category among its peers . The reason why the comparable model can be used in almost all circumstances is due to the vast number of multiples that can be utilized, such as the price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S), price-to-cash flow (P/CF), and many others. The P/E ratio is the most commonly used of these ratios because it focuses on the Khiron Life's earnings, one of the primary drivers of an investment's value.About Khiron Life Financial Statements
Khiron Life stakeholders use historical fundamental indicators, such as Khiron Life's revenue or net income, to determine how well the company is positioned to perform in the future. Although Khiron Life investors may analyze each financial statement separately, they are all interrelated. For example, changes in Khiron Life's assets and liabilities are reflected in the revenues and expenses on Khiron Life's income statement, which ultimately affect the company's gains or losses. Understanding these patterns can help in making the right long-term investment decisions in Khiron Life Sciences. Please read more on our technical analysis and fundamental analysis pages.
Khiron Life Sciences Corp. operates as an integrated medical and cannabis company in Latin America and Europe. Khiron Life Sciences Corp. was incorporated in 2012 and is headquartered in Vancouver, Canada. Khiron Life is traded on OTC Exchange in the United States.
Currently Active Assets on Macroaxis
Other Information on Investing in Khiron Pink Sheet
Khiron Life financial ratios help investors to determine whether Khiron Pink Sheet is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Khiron with respect to the benefits of owning Khiron Life security.